- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-02-0014295

About Plasoron Biotech Private Limited
Data last updated:
Plasoron Biotech Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 May 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2012PTC236591. Its GSTIN is 18AAHCM9546K1ZS (Assam). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹34 Lakh. It was formerly known as Mewell Biotech Private Limited and Wewell Biotech Private Limited. It is led by directors Kumar Indrajeet Singh and Prempal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R – 6 G/F Shop Kh No – 115/1, Main Road Bhrampuri, Delhi, India – 110053.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.46 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹36.23 Lakh (net margin 1.5%) and EBITDA of ₹76.35 Lakh (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 15% over five years.
The company has about 165 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5.47 Cr and satisfied charges of ₹4.49 Cr on record. Court records list 25 cases involving the company, including 13 filed by the company and 12 filed against it.
Plasoron Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0014295). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website plasoron.com.
Company details
Name history
Plasoron Biotech has undergone 2 name changes throughout its history. The company was previously known as Mewell Biotech Private Limited, and Wewell Biotech Private Limited. The current legal name is Plasoron Biotech Private Limited.
| Company Name | Status |
|---|---|
| Plasoron Biotech Private Limited | Current |
| Mewell Biotech Private Limited | Previous |
| Wewell Biotech Private Limited | Previous |
Recognitions & Rankings of Plasoron Biotech
Contact details
Plasoron Biotech Private Limited's registered office is in Delhi, Delhi. Its website is plasoron.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressR – 6 G/F Shop Kh No – 115/1, Main Road Bhrampuri, Delhi, India – 110053
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Plasoron Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Plasoron Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Plasoron Biotech Private Limited, buy the company report.
Financials of Plasoron Biotech Private Limited
FY 2025 filings availablePlasoron Biotech Private Limited reported revenue of ₹24.46 Cr (up 38% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 38% growth in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹76.35 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹36.23 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Plasoron Biotech Private Limited, buy the company report.
Board of directors of Plasoron Biotech Private Limited
Plasoron Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kumar Indrajeet Singh | Director | 28 May 2012 | 14 Years 5 Months | Current |
| Prempal | Director | 28 May 2012 | 14 Years 5 Months | Current |
Peer comparison
Plasoron Biotech Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vishwakrupa Pharma Private Limited | ₹24.79 Cr (FY 2025) | 8.0% | Ratnagiri, Maharashtra, India | |||
| Gal Care Pharmaceuticals Private Limited | ₹24.69 Cr (FY 2024) | 16.0% | Jaipur, Rajasthan, India | |||
| Bankura Jyotirmoyee Pharma Private Limited | ₹24.63 Cr (FY 2025) | 12.0% | West Bengal, India | |||
| Plasoron Biotech Private Limitedthis company | ₹24.46 Cr (FY 2024) | ₹36.23 Lakh | 1.5% | 38.0% | 165 | Delhi, India |
| Vega Health Care Pvt.Ltd. | ₹24.41 Cr (FY 2025) | -5.0% | Haryana, India | |||
| Shri Ganesh Associates Pharmaceuticals Private Limited | ₹24.38 Cr (FY 2025) | 22.0% | Chennai, Tamil Nadu, India | |||
| Spey Medical Private Limited | ₹24.33 Cr (FY 2025) | -30.0% | Bhorakalan, Haryana, India | |||
| Namanidhi Pharmaceutical Private Limited | ₹24.15 Cr (FY 2024) | 31.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Plasoron Biotech Private Limited, buy the company report.
Auditor
Plasoron Biotech Private Limited is audited by V C & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V C & Co | FY 2023 | 097138 |
Shareholding
The shareholding of Plasoron Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Plasoron Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Mar 2025 | 101070918 | Others | ₹52 Lakh | Open | |
| 27 Mar 2025 | 101070926 | Others | ₹4.95 Cr | Open | |
| 31 Dec 2022 | 100678648 | Others | ₹3 Cr | Satisfied | |
| 31 Dec 2022 | 100678673 | Others | ₹62.56 Lakh | Satisfied | |
| 22 Jul 2020 | 100363722 | State Bank of India | ₹46.34 Lakh | Satisfied |
To see the full charge records of Plasoron Biotech Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Plasoron Biotech Private Limited has 25 court cases on record: 13 filed by Plasoron Biotech, 12 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 15 | 12 | 0 |
| High courts | 10 | 0 | 0 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North, Delhi | Court case (MCA DJ) | Filed by the company against an individual | Disposed |
| High Court of Delhi | Court case (CM(M)) | Filed by the company against an individual | Disposed |
| District court, Central, Delhi | Criminal case | Filed against the company by an individual | Disposed |
| District court, Central, Delhi | Criminal case | Filed against the company by an individual | Disposed |
| District court, Shahdara, Delhi | Criminal case | Filed by the company against an individual | Disposed |
To see the full case history of Plasoron Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Plasoron Biotech Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 3 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Leroy Nutrascience |
To see the full MSME payment records of Plasoron Biotech Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Plasoron Biotech Private Limited has a workforce of 165 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
GST
Plasoron Biotech has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AAHCM9546K1ZS | Assam | Active | 01 Jul 2017 |
| 09AAHCM9546K1ZR | Uttar Pradesh | Active | 22 Jun 2022 |
To see the full GST registrations and return filing status of Plasoron Biotech Private Limited, buy the company report.
Recent activity
Plasoron Biotech Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Baban Dang ceased to be Director on 05 Jun 2014.
8 earlier events are in the company report.
Frequently asked questions
Plasoron Biotech is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 May 2012 (14+ years old) and is registered under CIN U51909DL2012PTC236591.
Plasoron Biotech has 2 current directors:
- Kumar Indrajeet Singh - Director
- Prempal - Director
The latest financial statements of Plasoron Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Plasoron Biotech is 18AAHCM9546K1ZS, registered in Assam. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 09AAHCM9546K1ZR (Uttar Pradesh).
The CIN (Corporate Identification Number) of Plasoron Biotech is U51909DL2012PTC236591. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Plasoron Biotech has 25 court cases on record: 13 filed by the company and 12 filed against it. Most are in the district courts.
Plasoron Biotech was incorporated on 28 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Plasoron Biotech by revenue are Vishwakrupa Pharma Private Limited, Gal Care Pharmaceuticals Private Limited, Bankura Jyotirmoyee Pharma Private Limited, Vega Health Care Pvt.Ltd, Shri Ganesh Associates Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Baban Dang ceased to be Director on 05 Jun 2014. Kumar Indrajeet Singh was appointed as Director on 28 May 2012. Prempal was appointed as Director on 28 May 2012.
Yes, Plasoron Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-DL-02-0014295).
Plasoron Biotech has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 3 overdue payments to 2 micro and small suppliers. The latest return was filed on 25 May 2019.
Plasoron Biotech can be reached through the website plasoron.com. Its registered office is in Delhi, India.

